contain a component which is reported to be a weak organophosphate-type cholinesterase inhibitor.
excessive exposure may produce organophosphate type cholinesterase inhibition.
sign and symptoms of excessive exposure may be headache, dizziness, incoordination, muscle twitching, tremors, nausea, abdominal cramps, diarrhea, sweating, pinpoint pupils, blurred vision, salivation, tearing, tightness in chest, excessive urination, convulsions.
contains component which have been reported to cause effects on the following organs in animal: heart.